Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema

Clinical Trial ID NCT01574248

Rank	Title	Journal	Year	PubWeight™‹?›
1	Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.	N Engl J Med	1998	3.18
2	Clinical practice. Hereditary angioedema.	N Engl J Med	2008	2.95
3	Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.	Clin Pharmacol Ther	1996	2.32
4	Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.	Hypertension	2009	2.04
5	Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).	J Allergy Clin Immunol	2007	1.52
6	Recurrent angiotensin-converting enzyme inhibitor--associated angioedema.	JAMA	1997	1.15
7	Angiotensin-converting enzyme inhibitor-associated angioedema.	Immunol Allergy Clin North Am	2006	1.12
8	An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.	Core Evid	2012	0.91
9	Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes.	Kidney Int	1994	0.85
10	Hereditary angioedema: epidemiology, management, and role of icatibant.	Biologics	2013	0.80
11	Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin.	Kidney Int	1998	0.77